• Citer

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

par D:A:D Study Group, Caroline;Sabin, Signe Westring;Worm, Rainer;Weber, Peter;Reiss, Wafaa;El-Sadr, François;Dabis, Stéphane ;De Wit, Mathew M.G.;Law, Antonella;d'Arminio Monforte, Nina;Friis-Møller, Ole;Kirk, Christian;Pradier, Ian;Weller, Andrew N.;Phillips, Jens D;Lundgren,
Référence Lancet, 371, 9622, page (1417-1426)
Publication Publié, 2008-04

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration
Auteur:	D:A:D Study Group, Caroline; Sabin, Signe Westring; Worm, Rainer; Weber, Peter; Reiss, Wafaa; El-Sadr, François; Dabis, Stéphane; De Wit, Mathew M.G.; Law, Antonella; d'Arminio Monforte, Nina; Friis-Møller, Ole; Kirk, Christian; Pradier, Ian; Weller, Andrew N.; Phillips, Jens D; Lundgren,
Informations sur la publication:	Lancet, 371, 9622, page (1417-1426)
Statut de publication:	Publié, 2008-04
Sujet CREF:	Sciences bio-médicales et agricoles
	Pathologie maladies infectieuses
MeSH keywords:	Adult
	Aged
	Aged, 80 and over
	Didanosine -- adverse effects -- therapeutic use
	Dideoxynucleosides -- adverse effects -- therapeutic use
	Female
	HIV Infections -- drug therapy
	Humans
	Male
	Middle Aged
	Myocardial Infarction -- chemically induced
	Poisson Distribution
	Reverse Transcriptase Inhibitors -- adverse effects -- therapeutic use
	Risk Factors
Langue:	Anglais
Identificateurs:	urn:issn:0140-6736
	info:doi/10.1016/S0140-6736(08)60423-7
	info:pii/S0140-6736(08)60423-7
	info:pmid/18387667
	PMC2688660